Retinitis Pigmentosa (RP) Completed Phase 3 Trials for Lutein (DB00137)

Also known as: Retinitis Pigmentosa / Pigmentary maculopathy / Albipunctate retinal dystrophy

IndicationStatusPhase
DBCOND0056216 (Retinitis Pigmentosa (RP))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00346333Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin ATreatment